Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely mesoridazine besilate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesoridazine besylate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesoridazine besilate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesoridazine besylate 25mg/mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesoridazine besylate 25mg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesoridazine besylate 10mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mesoridazine besilate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mesoridazine besilate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesoridazine besilate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesoridazine besylate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesoridazine besylate 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesoridazine besilate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesoridazine besilate 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesoridazine besilate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesoridazine besilate 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesoridazine besilate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesoridazine besylate 25 mg oral tablet |
Has precise active ingredient |
True |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesoridazine besilate 50 mg oral tablet |
Has precise active ingredient |
True |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesoridazine besilate 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Mesoridazine besylate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |